⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL
sunovionmapresentations.com · Technology
At 1.6/10, DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL is close to invisible in AI search today. Most assistants will not cite it when asked about your category - fixable, and the signals below show exactly where to start.
Monitoring for AI engine activity
In the Engagemii AEO index
#2,807,820 of 2,832,205 in Technology for AI visibility
1.6
/10
AEO Score
About DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL
from our crawl and measurement
DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL is a business whose own site puts it this way: "Live Session 9:00 AM ET 25 min Welcome & Opening: Virtual Environment & Annual Global Medical Affairs Report Andrei Pikalov 9:25 AM ET 5 min Global Perspectives, What are some of the." To AI engines like ChatGPT and Perplexity it is close to invisible, scoring 1.6 out of 10.
The site is missing structured data describing the business, an llms.txt file and a sitemap.
The 6 signals AI reads
Higher is better · 0-10
Structured Data
1
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
2
Clear headings and answer-style content.
Entity Clarity
3
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
0
Experience, Expertise, Authority, Trust markers.
Technical AEO
4
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
3
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
0
No inbound links found yet.
Domain Trust
0
Little domain authority yet.
Entity Presence
0
Not in AI knowledge graphs yet.
News Mentions
0
No press coverage found yet.
Community
0
No community discussion yet.
0
No Reddit mentions found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 1.6/10, DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL
Which AI engines already crawl you
Weekly ChatGPT & Claude citation tracking
Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL.
Source & Attribution
Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/sunovionmapresentations
Cite this score: Engagemii (2026). "AEO Score for DRUG DISCOVERY AND DEVELOPMENT: THE JOURNEY TO FDA APPROVAL." Retrieved from https://engagemii.com/aeo/brands/sunovionmapresentations
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform